Home / 2014 / June

Monthly Archives: June 2014




Comprehensive List of Insulins

comprehensive-insulin-tool-image

This 30-page printable pdf includes Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, and Pre-Mixed or Combination Insulins. Detailed information on these insulins includes: Indications, Pharmacology, Dosage and Administration, Adverse Effects, and Precautions and Contraindications.   Just click on this link for the 30-page PDF of the Comprehensive List of Insulins (updated October 30, 2015) …

Read More »

Editor’s Note, DCMS #195:

This week, our special text is our Comprehensive List of Insulins. The most comprehensive and up-to-date list available, this 22-page printable pdf includes Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, and Pre-Mixed or Combination Insulins. Our Disaster Averted looks at how hemoglobin variants can make an A1c test inaccurate, and our Homerun Slides focus …

Read More »

Letter from the Editor #735

It is interesting to listen to PCP’s and other prescribers talk about their reluctance to use GLP-1 analogs in their practice. This class of drugs had a great presence at this year’s ADA Scientific Sessions and many of the posters and presentations were focused on the practical use of these …

Read More »

Bionic Pancreas Effective for Type 1’s

FDA Approves Inhaled Insulin Afrezza for Diabetes. MannKind Corporation today announced that the FDA has approved AFREZZA® (insulin human) Inhalation Powder to improve glycemic control in adult patients with diabetes mellitus. More news to come. Bionic Pancreas Effective for Type 1’s. See this week’s Item #9.

Read More »

VBLOC® – Vagal Blocking Therapy for Weight Reduction

VBLOC-image

  VBLOC® – Vagal Blocking Therapy for Weight Reduction  VBLOC® is a first-in-class weight loss treatment designed to treat a range of gastrointestinal and metabolic diseases. Delivered by a pacemaker-like device called the Maestro® Rechargeable System,VBLOC Therapy is designed to block vagal nerve signaling between the brain and stomach believed to …

Read More »

Lorcaserin Improved Glucose Control Regardless of Weight Loss

A study of 509 type 2 diabetes patients found that lorcaserin was more effective than diet and exercise alone in reducing A1C levels regardless of whether the patients lost weight. The patients, randomly assigned to either lorcaserin or placebo along with diet and exercise, had A1c levels between 7% and …

Read More »